International Journal of Medicine and Data

Objective To observe the effect of Ateplase and recombinant streptokinase in emergency treatment of patients with ST segment elevation myocardial infarction. Methods Combined with the way of comparative treatment and observation, 86 patients were included in the study from February 2021 to June 2022. Double blind method was used to divide them into the control group (43 patients were treated with alteplase) and the observation group (43 patients were treated with recombinant streptokinase). The recovery of the two groups of patients was analyzed. Results Compared with the control group, the vascular recanalization rate in the observation group was significantly higher than that in the control group at 60 minutes, 90 minutes and 120 minutes after treatment, P<0.05. The incidence of adverse reactions in the observation group was lower than that in the control group (P<0.05). Statistics showed that the improvement time of ST segment elevation and chest pain symptoms in the two groups were shorter than those in the control group (P<0.05). Conclusion In the treatment of emergency patients with ST segment elevation myocardial infarction, selecting ateplase for treatment can ensure the patients vascular recanalization rate, reduce the incidence of adverse reactions, shorten the time for patients to improve their symptoms, and the effect is better than that of recombinant streptokinase.

recombinant streptokinase; Ateplase; Emergency ST segment elevation myocardial infarction